Related Experiment Videos
Galanin analogues: agonist and antagonist
N Yanaihara1, T Mochizuki, N Takatsuka
1University of Shizuoka, School of Pharmaceutical Sciences, Japan.
Regulatory Peptides
|July 2, 1993
Summary
Researchers synthesized galanin-related peptides to study their effects on physiological functions. The N-terminal 1-15 sequence is vital for galanin activity, and specific analogues show potential as antagonists for insulin release inhibition.
Area of Science:
- Peptide Synthesis and Pharmacology
- Endocrinology and Neuroscience
Background:
- Galanin is a neuropeptide implicated in various physiological processes.
- Understanding galanin's structure-activity relationship is crucial for therapeutic development.
Purpose of the Study:
- To synthesize and characterize galanin-related peptides.
- To investigate the functional roles of galanin and its analogues in key physiological systems.
- To identify specific sequences responsible for galanin's activity and develop antagonists.
Main Methods:
- Solid-phase and solution-phase peptide synthesis techniques were employed.
- Peptide purity was confirmed using standard analytical methods.
- Functional assays included isolated perfused rat pancreas, stomach, guinea pig ileum, and newborn rat spinal cord preparations.
Main Results:
- Twenty-three galanin-related peptides were successfully synthesized and purified.
- The galanin amino-terminal 1-15 sequence was identified as critical for activity across four tested systems.
- Specific synthetic analogues, [D-Thr6,D-Trp8,9]galanin(1-15)ol and [D-Trp8,9]galanin(1-15)ol, demonstrated potent antagonism of galanin's inhibitory effect on glucose-induced insulin release.
Conclusions:
- The N-terminal region (1-15) of galanin is essential for its diverse physiological actions.
- Novel synthetic galanin analogues can act as specific antagonists, particularly for modulating insulin secretion.
- These findings pave the way for developing targeted therapies involving galanin signaling pathways.